Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Lanreotide acetate

EU orphan designation number: EU/3/15/1514   
Active ingredient: Lanreotide acetate
Indication: Treatment of autosomal dominant polycystic kidney disease
Sponsor: Prof. Dr R.T.Gansevoort
Dept. Nephrology, University Medical Center Groningen, PO Box 30.001, 9700 RB Groningen, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/08/2015 Orphan designation EMA/OD/027/15 (2015)5767 of 10/08/2015